Why do people with Crohn's and Colitis flare?
This is the fundamental question we set out to answer when we started the PREdiCCt study in 2016.
On Tuesday, the first major results will be published in @Gut_BMJ
We wanted to look beyond just the clinical data. We focused on the environment: diet, lifestyle, exercise, sleep, and stress. By combining these factors with the microbiome and genetics, we aimed to understand the true drivers of disease activity over time.
This has been a decade in the making.
We recruited 2,629 patients across 49 adult and pediatric sites before the pandemic halted recruitment in March 2020. Since then, our team has been busy assimilating years of follow up data. Most participants have now been followed for over four years.
In this video, I talk through the background and design of the study. It represents a massive collective effort from clinical trials units, statisticians, and project managers.
Most importantly, it represents the dedication of the people living with IBD who gave their time to this research. Our goal is to provide the evidence needed to help patients stay in deep remission and to help clinical teams provide better, more personalized care.
I look forward to sharing the findings with you this week.
@EdinUni_IGC@EdinburghUni@NHS_Lothian@IBDNathan@predicct@Bealoquebea @PlevrisN @UKRI_News
Canโt believe 6 months of intern year have gone by. General surgery is intense โ the workload is heavy and exhausting. Balancing residency, research, and everything else outside the hospital has been a huge challenge. Excited for whatโs ahead! #internyear#residency#surgery
Are IBD patients & their families ready for prediction + prevention? โ Yes! Time for the IBD community to unite & make it happen. https://t.co/Lq8Sa526cA
Day 3 of the Brazilian IBD Conference ๐ง๐ท & 1st EIICOSUR ๐จ๐ฑ ๐ฆ๐ท๐บ๐พ๐ต๐พโ sharing knowledge, strengthening #IBD care across #LATAM!
Excellent lectures & a great chance to reconnect with colleagues and friends.
#SEBRADII#EIICOSUR#Gastroenterology#InflammatoryBowelDisease
Our IBD team (nurses, GIs, peds, dietitians) reunited to discuss about IL23 inhibitors. Thanks @JanssenUS for the support. #ibd#ibdresearch#latam
@Unesp_Global
Really interesting findings on the PPI use and risk of GI toxicity of patients under checkpoint inhibition
โ๏ธโ๏ธData on lower toxicity
โdifferences in the overall survival!!!!!
Such a great topic to dive into impressive results
Congratulations for the work Malek Shatila at @DDWMeeting #DDW2024
Have you seen our recently launched #CareerDevelopment on writing a good systematic review & meta-analysis? It's UEG's newest activity to help you deepen your writing expertise and connect with peers!
Enrol now https://t.co/7ZH8pI4Bym
#myUEGcommunity#IngestTheBest#UEGEdu